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Abstract Bioactive glass (BAG) and polymethyl meth-
acrylate (PMMA) have been used in clinical applications.
Antimicrobial BAG has the ability to attach chemically to
surrounding bone, but it is not possible to bend, drill or
shape BAG during the operation. PMMA has advantages in
terms of shaping during the operation, but it does not attach
chemically to the bone and is an exothermic material. To
increase the usefulness of BAG and PMMA in skull bone
defect reconstructions, a new composite implant containing
BAG and PMMA in craniofacial reconstructions is pre-
sented. Three patients had pre-existing large defects in the
calvarial and one in the midface area. An additive manufac-
turing (AM) model was used preoperatively for treatment
planning and custom-made implant production. The trunk
of the PMMA implant was coated with BAG granules.
Clinical and radiological follow-up was performed postop-
eratively at 1 week, and 3, 6 and 12 months, and thereafter
annually up to 5 years. Computer tomography (CT) and
positron emission tomography (PET-CT) were performed
at 12 and 24 months postoperatively. Uneventful clinical
recovery with good esthetic and functional outcome was
seen. CT and PET-CT Wndings supported good clinical
outcome. The BAG–PMMA implant seems to be a promising
craniofacial reconstruction alternative. However, more
clinical experience is needed.
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Introduction
Traditional skull and facial bone reconstructions with hard
tissues have a long history with good clinical outcomes [1–3].
However, they have certain disadvantages, e.g., donor site
morbidity [4]. The beneWts of synthetic materials are not
only the avoidance of donor site morbidity and scars, but
also shorter hospitalization time, lower expenses and
known composition [5]. Metallic implants have been used
alone [6] or combined with bone or hydroxyapatite cement in
cranial bone reconstructions [7]. Polymethyl methacrylate
(PMMA) resin, polyethylene and hydroxyapatite with
various formulations have been utilized in cranial bone
reconstructions [8, 9]. Although these materials are readily
available for immediate application, they all require prepara-
tion, adaptation and contouring into the defect and, later on,
resistance to traumatic insults is uncertain. Additive manu-
facturing technology (AM) has been applied to many medical
specialties [10–13]. A custom-made skull bone implant can
be produced based on the patient’s preoperative AM three-
dimensional mode, and this will result in very high accuracy
in terms of the form of the skull defect [14].
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Composite implant materials
PMMA is one of the most widely used alloplastic materials
in surgery [8, 15]. It has the advantages of being relatively
well tolerated by soft tissues and of having a density similar
to that of the bone, as well as low thermal conductivity. How-
ever, in situ use of PMMA, i.e., a resin mixture of polymer
powder and monomer, causes an exothermic reaction by
free-radical polymerization. In addition, foreign-body reac-
tion with polymethyl methacrylate has been observed [15].
Bioactive glass S53P4 (BAG) particles of the composi-
tion SiO2 53.0; CaO 20.0; Na2O 23.0; P2O5 4.0 wt% have
been used in various clinical indications [16–18]. EVects of
BAG and clinically important bacteria have been studied
experimentally [19, 20]. Microbes lost their viability when
placed in contact with BAG [19, 20].
BAG is a brittle and rigid material. It is not possible to
drill, bend or shape BAG during the reconstruction opera-
tion. Preoperative mechanical preparation of brittle BAG
for individual implants is diYcult because of the risk of
microscopic fractures in the BAG implant, probably
leading to an unsafe individual implant. PMMA has advan-
tages in terms of shaping during the operation, but it does
not attach chemically to the bone and it is an exothermic
material. To variegate BAG and PMMA usefulness in skull
bone defect reconstructions, a new composite implant
containing BAG granules and PMMA is presented.
Materials and methods
Patients
Of four male patients (mean age of 41 years, range 19–66
years), three needed calvarial and one facial bone defect
reconstruction (Table 1). The patients were operated in
2005–2006 in the Turku University Hospital Department of
Otorhinolaryngology, Head and Neck Surgery. The study
plan was reviewed and approved by the Joint Commission on
Ethics of Turku University and Turku University Hospital.
Implants
The defect in the patient’s skull (Fig. 1) was detected with a
preoperative high-resolution three-dimensional CT study.
With the help of the AM (Alphaform Ltd, Rusko, Finland),
a custom-made implant (Fig. 2) was prepared by hand
(Tables 2, 3). The resin matrix of the implant was a pow-
der–liquid system PMMA bone cement (Palacos-R®, Her-
aueus Kulzer GmbH, Germany), and the surface of both
sides of the implant was covered with exposed particles of
BAG 0.5–0.8 mm in size (BonAlive™, BonAlive Biomate-
rials Ltd., Finland). The implant’s PMMA trunk was perfo-
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rated with holes 1.5 mm in diameter (Figs. 2, 3) to enhance
tissue ingrowth [21, 22] into the implant and body Xuid per-
fusion (Figs. 2, 3). On the upper surface of the implant, a
screw Wxation rim with a thickness of 1.0 mm was used to
insure the correct position of the implant in the calvarial
bone defect and to prevent the implant from sinking too
deep into contact with the lamina dura (Fig. 3). The implant
was polymerized by autopolymerization, followed by
Wnishing of the contour surfaces of the implant. Then, the
implant was post-cured at a temperature of 120°C to
optimize the degree of PMMA monomer conversion, thus
reducing the quantity of residual monomers in the Wnal
implant [23,  24]. The implant was sterilized with the
gamma sterilization method preoperatively with a 25 kGy
irradiation dose and double packed for clinical use (Isotron
Nederland, Netherlands).
Implantation technique
The defect site was prepared by isolation of the bone mar-
gins through underlying dural and overlying soft tissue
dissection. The bony walls of the defects were completely
Fig. 1 Photograph of a patient after a car accident. Defect (arrow)
from left lateral view (patient 2)
Fig. 2 Additive manufacturing model of a large left calvarial bone
defect and a custom-made PMMA and BAG implant before operation
(patient 2)
Table 2 Composition of PMMA and BAG in weight%
Palacos® PMMA bone cement BonAlive™ 0.5–0.8 mm granules
Methyl methacrylate 83.5% Silicon dioxide 53%
Silicon dioxide 14.3% Sodium dioxide 23%
Benzoyl peroxide 1.0% Calcium oxide 20%
Gentamicin 1.2% Phosphorus pentoxide 4%
Table 3 Detailed implant composition and weight
Each implant was sterilized with gamma sterilization at 25 kGy
Patient 
number
Implant components and weight in grams
1 PMMA 86 g
BAG 12 g (on both sides of implant)
Total weight 98 g
2 PMMA 60 g
BAG 8 g (on both sides of implant)
Total weight 68 g
3 PMMA 4.5 g
BAG 1 g (on lower side of implant)
Total weight 5.5 g
4 PMMA 67 g
BAG 10 g (on both sides of implant)
Total weight 77 g
Fig. 3 The outer surfaces of the implants were covered with BAG
granules. The PMMA trunk of the implant was perforated with
1.5 mm perforations to enhance tissue growth into the implant. The
implant was adjusted to its correct position in the skull (patient 1)626 Eur Arch Otorhinolaryngol (2012) 269:623–628
123
removed from soft tissue. The implants were applied to
the bone defects, and the correct position of the implant
was ensured with screw Wxation (Table 1; Figs. 2, 3). Only
minor adjustment of the implants was made with a hand
piece and burr under physiologic saline irrigation to
achieve accurate implant Wt into bony defects. An intraoral
approach was used in one patient, whose lateral midface
fracture in the right side could not be adequately recon-
structed in three previous operations (Table 1, Fig. 4).
Follow-up examinations
The results of the clinical examinations and patients’ symp-
toms were recorded at 1 week, and 1, 3, 6 and 12 months,
and thereafter, annually up to 5 years postoperatively
(Table 1). Lateral skull X-ray pictures were obtained at each
observation point and CT at 12 months. PET-CT from two
patients was performed at 24 months postoperatively. Rou-
tine hematologic tests including C-reactive protein (CRP)
and creatinine were carried out at postoperative controls
only in the case of clinical need. In clinical examinations,
special attention was paid to a progressive healing process
with diminishing postoperative pain, skin wound healing
and clinical position of the implant. In CT or skull X-ray
studies, special attention was paid to the border between the
implant and surrounding bone to detect any deviations of the
permanent Wt of the implant into the original defect (Fig. 5).
In PET-CT with (18)F-Xuoride ion marker, signs of activity
of new bone formation between the bone defect margin and
the implant were examined (Fig. 6).
Results
Although the defects needed large bone reconstructions
(Table 1; Figs. 1–4), there was no mortality. After operation,
in the early phase of clinical follow-up from 1 week to
3 months, a progressive healing process with diminishing
postoperative clinical symptoms and normally progressing
skin wound healing was seen. In skull X-ray studies and
clinical examinations, the implants were in the original posi-
tions (Figs. 2, 3, 5). Thereafter, the postoperative course was
uneventful. However, there was no donor site morbidity
because the custom-made implants did not need any graft
operations. As a complication, one of the skull bone defect
patients had epidural hemorrhage immediately after the
Fig. 4 Custom-made BAG and PMMA implant before secondary
reconstruction (patient 3)
Fig. 5 CT picture of implant 2 years after reconstruction. Implant is in
the correct position in the skull. Slight new bone formation between
implant and surrounding bone is seen (white arrows, patient 1)
Fig. 6 PET-CT picture of implant 2 years after reconstruction. (18)F-
Xuoride marker was used. The implant is in the correct position in the
skull. Metabolic activity is shown with colors (white arrows). The
highest activity is shown with red and yellow, while green shows lower
activity. The middle arrow shows activity on the implant’s outer sur-
face (yellow and red areas), while the other two arrows show activity
at the border between the implant and bone (yellow and red areas,
patient 1)Eur Arch Otorhinolaryngol (2012) 269:623–628 627
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operation, which needed surgical intervention. Thereafter,
the postoperative course was uneventful. The early and the
late esthetic and functional outcomes were good in all three
calvarial reconstruction patients, and a satisfactory outcome
was achieved with orbit reconstruction (Figs. 5, 7). Hemato-
logic tests revealed no abnormal Wndings throughout the
study. At 2 years postoperatively, both CT and PET-CT
studies were performed. In CT studies, the implants were in
the original position and an impression of new bone forma-
tion was seen (Fig. 5). PET-CT showed activity [25,  26]
similar to that reported before with bone healing (Fig. 6).
Discussion
Reconstruction of a large skull bone defect is one of the most
demanding challenges for surgeons. The gold standard with
long clinical experience in bone reconstruction is the use of
autogenic bone [1]. However, this method has a disadvan-
tage, namely, donor site morbidity [4] and sometimes enough
autogenic tissue for large bone reconstructions or new opera-
tions is not available. In this study, three large skull bone
defect reconstructions and one orbit reconstruction with a
new implant containing BAG and PMMA are presented. AM
technologies were utilized in both preoperative planning and
in custom-made implant manufacturing. The patients were
followed up for up to 5 years. In the present series, there
were no long-term complications such as implant-induced
skull resorption, loosening of implant or later infections. The
esthetic and functional outcomes were good. The combination
of biomaterials and AM can oVer novel solutions for diYcult
skull bone reconstructions.
Exposed BAG particles on the surface of the PMMA
implant improves bone formation at the interface of the
PMMA implant and surrounding bone [27]. In addition, the
perforated surface of the implant favors tissue ingrowth of
the implant [21, 22]. The bone growth between implant and
skull will result in Wrm adhesion, which in turn may prevent
long-term complications. In this study, supposed new bone
formation [27] was seen indirectly between an implant and
surrounding bone (Figs. 5, 6). These results are similar to
those reported before with bone healing [25,  26]. The
advantages of the presented composite material are the bio-
activity and osteoconductivity of BAG [27], including anti-
microbial properties shown in experimental studies [16, 19,
20]. The implants contain no metals related to artefacts in
imaging studies, e.g., in CT and MRI [11]. The implant can
be Wxed with screws or sutures or even set without speciWc
Wxation into the calvarial defect under soft tissues. The
implant can be shaped with manual and hand-piece instru-
ments. In addition, BAG particles and PMMA can be added
to the implant in clinical conditions, when it is necessary to
make the implant larger or stronger, e.g., in the case of a
larger postoperative defect than estimated in preoperative
planning. Donor site morbidity is not related to the custom-
made BAG and PMMA composite implant.
In bone reconstruction with biomaterials, the most impor-
tant practical factors are an adequate knowledge of the bio-
materials, their advantages and disadvantages, and the exact
composition of the used composite material (Tables 2,  3).
Irritation reactions because of exothermic polymerization of
PMMA and the presence of free and residual PMMA mono-
mers before and after polymerization [15] can be minimized,
when the implant is manufactured in controlled conditions
before the operation [23, 24, 28–30]. The total cost of the
implant in this study was 2,500 D. However, the shortening
of the operating time decreases the total costs of implant
reconstruction compared to conventional methods [5, 7, 12].
In the future, the new industrial manufacturing methods will
probably reduce the price of the implant.
However, a longer clinical follow-up with more patients
is needed before Wnal conclusions can be drawn about the
presented composite implant.
ConXict of interest The authors declare that they have no conXict of
interest.
Open Access This article is distributed under the terms of the Cre-
ative Commons Attribution Noncommercial License which permits
any noncommercial use, distribution, and reproduction in any medium,
provided the original author(s) and source are credited.
References
1. Tessier P, Kawamoto H, Matthews D et al (2005) Autogenous bone
grafts and bone substitute—tools and techniques: I A 20000-case
Fig. 7 Patient, 2 years after reconstruction (patient 2). Good
functional and esthetic outcome is seen628 Eur Arch Otorhinolaryngol (2012) 269:623–628
123
experience in maxillofacial and craniofacial surgery. Plast Reconstr
Surg Suppl 5:6–24
2. Lenz JH, Henkel KO, Hingst V, von Versen R, Gundlach K (2003)
Reconstruction of the frontal calvarial continuity in a child using
freeze-preserved autogenous bone grafts. J Craniomaxillofac Surg
3:154–158
3. Rodrigues M, O`Malley BW Jr, Staecker H, Tamargo R (2004)
Extended pericranial Xap and bone graft reconstruction in anterior
skull base surgery. Otolaryngol Head Neck Surg 1:69–76
4. Ahlmann E, Patzakis M, Roidis N et al (2002) Comparison of ante-
rior and posterior iliac crest bone grafts in terms of harvest-site mor-
bidity and functional outcomes. J Bone Joint Surg Am 5:716–720
5. Eppley BL (1999) Alloplastic implantation. Plast Reconstr Surg
104:1761–1783
6. Winder J, Cooke RS, Gray J et al (1999) Medical rapid prototyp-
ing and 3D CT in the manufacture of custom made cranial titanium
plates. J Med Eng Technol 1:26–28
7. Ducic Y (2002) Titanium mesh and hydroxyapatite cement
cranioplasty: a report of 20 cases. J Oral Maxillofac Surg 3:272–276
8. Moreira-Gonzalez A, Jackson IT, Miyawaki T et al (2003) Clini-
cal outcome in cranioplasty: critical review in long-term follow-
up. J Craniofac Surg 5:144–153
9. Kveton JF, Coelho DH (2004) Hydroxyapatite cement in temporal
bone surgery: a 10 year experience. Laryngoscope 1:33–37
10. Mankovich NJ, Samson D, Pratt W et al (2005) Surgical planning
using three-dimensional imaging and computer modeling. Otolar-
yngol Clin North Am 5:875–879
11. Winder J, Bibb R (2005) Medical rapid prototyping technologies:
state of the art and current limitations for application in oral and
maxillofacial surgery. J Oral Maxillofac Surg 63:1006–1015
12. Suzuki M, Ogawa Y, Kawano A et al (2004) Rapid prototyping of
temporal bone for surgical training and medical education. Acta
Otolaryngol 4:400–402
13. Sarment DP, Sukovic P, Clinthorne N (2003) Accuracy of implant
placement with a stereolithographic surgical guide. Int J Oral
Maxillofac Implants 4:571–577
14. Eppley BL, Kilgo M, Coleman JJ III (2002) Cranial reconstruction
with computer-generated hard-tissue replacement patient-matched
implants: indications, surgical technique, and long-term follow-
up. Plast Reconstr Surg 109:864–871
15. Stelnicki EJ, Ousterhout DK (1996) Prevention of thermal injury
induced by the application of polymethylmetacrylate to the calvar-
ium. J Craniofac Surg 7:192–195
16. Peltola M, Aitasalo K, Suonpää J et al (2006) Bioactive glass
S53P4 in frontal sinus obliteration: a long-term clinical experience.
Head Neck 28:834–841
17. Turunen T, Peltola J, Yli-Urpo A et al (2004) Bioactive glass
granules as a bone adjunctive material in maxillary sinus Xoor aug-
mentation. Clin Oral Implants Res 2:135–141
18. Lindfors NC, Heikkilä JT, Koski I, Mattila K, Aho AJ et al (2009)
Bioactive glass and autogenous bone as a bone graft substitutes in
benign bone tumors. J Biomed Mater Res B Appl Biomater 90:
131–136
19. Leppäranta O, Vaahtio M, Peltola T et al (2008) Antibacterial
eVect of bioactive glasses on clinically important anaerobic bacte-
ria in vitro. J Mater Sci Mater Med. 19:547–551
20. Munukka E, Leppäranta O, Korkeamäki M et al (2008) Bacterici-
dial eVects of bioactive glasses on clinically important aerobic
bacteria. J Mater Sci Mater Med. 19:27–32
21. Hulbert SF, Young FA, Mathews RS et al (1970) Potential of
ceramic materials as permanently implantable skeletal prostheses.
J Biomed Mater Res 4:433–456
22. Klawitter JJ, Bagwell JG, Weinstein AM, Sauer BW (1976) An
evaluation of bone ingrowth into porous high density polyethylene.
J Biomed Mater Res 10:311–319
23. Vallittu PK, Ruyter IE, Buykuilmaz S (1998) Polymerization time
and temperature eVects the residual monomer content of denture
base polymers. Eur J Oral Sci 106:588–593
24. Viljanen EK, Skrifvars M, Vallittu PK (2004) Degree of conver-
sion of an experimental monomer and methyl methacrylate
copolymer for dental applications. J Appl Polym Sci 93:1908–
1912
25. Hsu W, Feeley BT, Krenek L et al (2007) The use of 18F-Xuoride
and 18F-FDG PET scans to assess fracture healing in a rat femur
model. Eur J Nucl Med Mol Imaging 34:1291–1301
26. Ullmark G, Sörensen J, Nilsson O (2009) Bone healing of severe
acetabular defects after revision arthroplasty. Acta Orthop 80:
170–183
27. Heikkilä JT, Aho AJ, Kangasniemi I et al (1996) Polymethylmet-
acrylate composites: disturbed bone formation at the surface of
bioactive glass and hydroxylapatite. Biomaterials 18:1755–1760
28. Saha S, Pal S (1984) Mechanical properties of bone cement: a
review. J Biomed Mater Res 18:435–462
29. Ginebra MP, Gil FX, Plaanell JA et al (1996) Relationship
between morphology of PMMA particles and properties of acrylic
bone cements. J Mater Sci Mater Med 7:375–379
30. Vallittu PK, Miettinen V, Alakuijala P (1995) Residual monomer
content and release into water of denture polymethyl methacrylate.
Dent Mater 11:338–342